If any of these products could benefit patients in your market, please don’t hesitate to contact us.
We specialise in producing prescription drugs for various therapeutic areas including oncology, dermatology, the central nervous system, and immunology.
Strength: 10 mg, 17.5 mg, 22.5 mg, 25 mg
Form: Capsules
Dossier available: Yes
Branded generic available: NovatretinTM
Strength: 10 mg, 30 mg
Form: Softgel capsules
Dossier available: Yes
Branded generic available: ZemataneTM
Strength: 25 mg, 50 mg, 75 mg and 100 mg
Form: Tablets
Dossier available: Yes
Branded generic available: AzamunTM
Strength: 75 mg
Form: Softgel capsules
Dossier available: Yes
Strength: 25mg, 50mg, 100mg, 200mg
Form: Tablets
Dossier available: Yes
Branded generic available: ClopineTM
Strength: 50 mg/ml
Form: Oral suspension
Dossier available: Yes
Branded generic available: Yes
Strength: 50 mg, 100 mg
Form: Tablets
Dossier available: Yes
Strength: 35mcg/2mg
Form: Tablets
Dossier available: Yes
Branded generic available: EstelleTM
Strength: 5 mg, 10 mg, 20 mg, 30 mg, 40 mg
Form: Softgel capsules
Dossier available: Yes
Branded generic available: OrataneTM
For detailed technical specifications, regulatory dossiers, prescribing information (PI), manufacturing process data, and confidential commercial terms, please contact us.
See our products under development, view the Douglas 505(b)(2) and 505(j) pipelines here.